You appear to be offline. Some data may be unavailable until your connection is restored.

GILD

Stock

Gilead Sciences Inc

Create price alert
$167.95
-$1.78 (1.05%)
At close: Nov 12, 2026, 4:00 PM

Description

Gilead Sciences Inc. is a research‑driven biopharmaceutical company that discovers, develops and markets therapeutic medicines, most notably antiviral drugs for HIV/AIDS, hepatitis B and C, and more recently COVID‑19, as well as oncology, inflammatory and cell‑therapy products. It operates within the biotechnology and pharmaceutical sector, leveraging a strong R&D pipeline and strategic partnerships to bring new treatments to market. Gilead is recognized as a global leader in antiviral therapy, having built a dominant position with flagship HIV regimens and breakthrough hepatitis C cures, and is actively expanding its presence in cancer and specialty disease areas.

Price Chart

Market just opened
Intraday data has a 15-minute delay. Chart will appear shortly.
Intraday data unavailable

Never miss a move in GILD

Set alerts for price targets, percentage moves, trailing stops, market open and close prices, after-hours and pre-market changes, new 52-week highs and lows, and more. Get notified the moment they happen.

Create price alert

Other Healthcare stocks in the S&P 500

View all S&P 500 pharmaceutical stocks →View all S&P 500 Healthcare stocks →View all S&P 500 stocks →